Emcure Pharmaceuticals Limited
| Opening Date | Closing Date | Face Value | Issue Price | Lot Size | Listing At | Total Issue Size | Basis of Allotment | Initiation of Refunds | Credit of Shares to Demat | Listing Date |
|---|---|---|---|---|---|---|---|---|---|---|
| 03-07-2024 | 05-07-2024 | 10 | 0 | 14 Shares | BSE, NSE | 19,365,346 shares (aggregating up to ₹1,952.03 Cr) | 2024-07-08 00:00:00 | 2024-07-09 00:00:00 | 2024-07-09 00:00:00 | 10-07-2024 |
About The Company
Emcure Pharma IPO is a book built issue of Rs 1,952.03 crores. The issue is a combination of fresh issue of 0.79 crore shares aggregating to Rs 800.00 crores and offer for sale of 1.14 crore shares aggregating to Rs 1,152.03 crores.
Emcure Pharma IPO opens for subscription on July 3, 2024 and closes on July 5, 2024. The allotment for the Emcure Pharma IPO is expected to be finalized on Monday, July 8, 2024. Emcure Pharma IPO will list on BSE, NSE with tentative listing date fixed as Wednesday, July 10, 2024.
Emcure Pharma IPO price band is set at ₹960 to ₹1008 per share. The minimum lot size for an application is 14 Shares. The minimum amount of investment required by retail investors is ₹14,112. The minimum lot size investment for sNII is 15 lots (210 shares), amounting to ₹211,680, and for bNII, it is 71 lots (994 shares), amounting to ₹1,001,952.
Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited and Jefferies India Private Limited are the book running lead managers of the Emcure Pharma IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Emcure Pharma IPO RHP for detailed information.
Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrow |
|---|---|---|---|---|---|---|
| 31-03-2024 | 7806 | 6715 | 528 | 2952.28 | 2722.4 | 2091.94 |
| 31-03-2023 | 6673 | 6032 | 562 | 2501.13 | 2293.77 | 2202.42 |
| 31-03-2022 | 6063 | 5919 | 703 | 1987.55 | 1791.03 | 2102.19 |
IPO Subscription Status
| Category | Subscription Times |
|---|---|
| Anchor Investors | 1 |
| Qualified Institutions | 0.97 |
| Non-Institutional Buyers | 13.97 |
| bNII (bids above ₹10L) | 14.44 |
| sNII (bids below ₹10L) | 13.03 |
| Retail Investors | 3.53 |
| Employees | 4.88 |
| Total | 5.00 |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | 14112 |
| Retail (Max) | 14 | 196 | 197568 |
| S-HNI (Min) | 15 | 210 | 211680 |
| S-HNI (Max) | 70 | 980 | 987840 |
| B-HNI (Min) | 71 | 994 | 1001952 |
IPO Listing Details
| Listing Date | 10-07-2024 |
| BSE Script Code | - |
| NSE Symbol | - |
| ISIN | - |
| Final Issue Price | 0 |
Promoter holdings
Satish Mehta and Sunil Mehta are the company promoters.
Contact Information of the Company
Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033
Email: investors@emcure.co.in
Website: https://www.emcure.com/
IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: emcure.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
IPO Lead Manager
Kotak Mahindra Capital Company Limited (Past IPO Performance) Axis Capital Limited (Past IPO Performance) J.P. Morgan India Private Limited (Past IPO Performance) Jefferies India Private Limited (Past IPO Performance)